礼来口服减肥药orforglipron在维持治疗中首证疗效。
Lilly’s orforglipron is the first oral obesity therapy to show its worth in the maintenance setting
生物技术与制药领域的最新动态
Lilly’s orforglipron is the first oral obesity therapy to show its worth in the maintenance setting
Steve Paul's post-Karuna act draws $165M to schizophrenia biotech Syremis
Union Bancaire Privee UBP SA Acquires Shares of 5,850 Waters Corporation $WAT - MarketBeat
Will Waters Corporation (WAZ) stock rise with strong economy - July 2025 Price Swings & Low Risk High Reward Trade Ideas - Улправда
Failure Analysis of Automotive Coating Defects - AZoM
Agilent Technologies (NYSE:A) Is Increasing Its Dividend To $0.255 - simplywall.st
Agilent Technologies (NYSE:A) Is Increasing Its Dividend To $0.255 - simplywall.st
Czech National Bank Buys 3,634 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Roche and Novartis close to price agreement with Trump - medwatch.com
Balefire LLC Raises Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding
How to transfer data from BaseSpace to Illumina Connected Software - Illumina
Illumina, Inc. $ILMN Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat
Agilent Technologies (NYSE:A) Is Increasing Its Dividend To $0.255 - Sahm
Illumina Inc (NASDAQ:ILMN) Nasdaq Futures Shape Discovery Market Now - Kalkine Media
Lindus Health and Quotient team up to create one-stop shop for early to mid-stage trials
Voyager jettisons 30 employees, Novartis hands back rights to 2 programs
Testosterone-induced metabolic changes in seminal vesicle epithelium modify seminal plasma components with potential to improve sperm motility
Slowing the growth of drug-resistant tumors
Empower Pharmacy cuts hundreds of staff, stops New Jersey operations